Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies.
暂无分享，去创建一个
D. V. Von Hoff | D. Durden | W. Qi | D. Mahadevan | W. Harris | J. Garlich | E. Chiorean | S. Anthony | A. Younger | R. Ramanathan | R. Ramanathan | M. Becker | F. Cordova | D. Rensvold | W. Qi | A. Stejskal-Barnett | C. Shelton | D. Hoff